Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$61.00K$61.00Kderived+1,120.0% vs Q4 2013 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$61,000+1,933.3%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Operating Cash Flowderived$53,000+65.6% ended Dec 31, 2014 · filed Mar 24, 2015 · 83 d after period end